All In Biotech

Free tool

FAERS Monitor: Betapace

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 019865 or its brand name (Betapace, Sotalol Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

3,865

Serious

3,025

78% of reports

Hospitalization

1,677

Death reported

400

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • atrial fibrillation355
  • drug ineffective220
  • dyspnoea219
  • dizziness189
  • hypotension189
  • fatigue183
  • nausea182
  • electrocardiogram qt prolonged157
  • asthenia149
  • diarrhoea142
  • bradycardia137
  • fall123
  • drug interaction117
  • chest pain105
  • death105

Reports by year received

View as table
YearReports
2004139
200592
2006210
2007283
200897
2009178
2010133
2011165
2012198
2013122
2014166
2015142
2016146
2017168
2018187
2019187
2020143
2021127
2022170
2023167
2024210
2025267
2026168

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,050,294 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (500). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
electrocardiogram qt prolongedSignal15723.920.53,406
atrial fibrillationSignal35519.918.06,362
hypotensionSignal1895.14.5630
drug interactionSignal1174.03.4264
astheniaSignal1492.21.893
dyspnoeaSignal2192.11.9129
dizzinessSignal1892.11.8105
fallSignal1232.01.763
fatigue1831.31.111
nausea1821.31.19
diarrhoea1421.21.05
drug ineffective2200.90.82
death1050.70.518
bradycardia1370.00.0740,723
chest pain1050.00.0566,439

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.